| Dr Christopher Cutright, OD | |
|
792 Silver Bluff Rd, Aiken, SC 29803 | |
| (803) 642-9902 | |
| (803) 642-8611 |
| Full Name | Dr Christopher Cutright |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 22 Years |
| Location | 792 Silver Bluff Rd, Aiken, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497717433 | NPI | - | NPPES |
| D12902 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1290 (South Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eye Care Associates Of Sc Llc | 4587998802 | 57 |
News Archive
Dispelling the belief that the only way to treat such conditions is by fixing or replacing damaged genes, they instead focused on the field of epigenetics—the study of changes in gene silencing that occur without changes in the genes themselves.
The US Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has voted unanimously in support of the use of Signifor (pasireotide) for the treatment of patients with Cushing's disease who require medical therapeutic intervention.
Democrats are finding points they agree on in a tenuous accord for the message they want to relay to constituents during the August recess: The health insurance industry is the bad guy, The Washington Post reports.
In breakthrough colon cancer research, scientists at Christiana Care Health System's Center for Translational Cancer Research of the Helen F. Graham Cancer Center & Research Institute have discovered that over-expression of HOXA4 and HOXA9 genes in colon cancer stem cells promotes cell replication and contributes to the overpopulation of stem cells that drives colon cancer development.
› Verified 4 days ago
| Provider Name | Specs Vision Center Of Aiken Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1912058900 PECOS PAC ID: 0941245294 Enrollment ID: O20050627001024 |
News Archive
Dispelling the belief that the only way to treat such conditions is by fixing or replacing damaged genes, they instead focused on the field of epigenetics—the study of changes in gene silencing that occur without changes in the genes themselves.
The US Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has voted unanimously in support of the use of Signifor (pasireotide) for the treatment of patients with Cushing's disease who require medical therapeutic intervention.
Democrats are finding points they agree on in a tenuous accord for the message they want to relay to constituents during the August recess: The health insurance industry is the bad guy, The Washington Post reports.
In breakthrough colon cancer research, scientists at Christiana Care Health System's Center for Translational Cancer Research of the Helen F. Graham Cancer Center & Research Institute have discovered that over-expression of HOXA4 and HOXA9 genes in colon cancer stem cells promotes cell replication and contributes to the overpopulation of stem cells that drives colon cancer development.
› Verified 4 days ago
| Provider Name | Eye Care Associates Of Sc Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1679046569 PECOS PAC ID: 4587998802 Enrollment ID: O20190620000990 |
News Archive
Dispelling the belief that the only way to treat such conditions is by fixing or replacing damaged genes, they instead focused on the field of epigenetics—the study of changes in gene silencing that occur without changes in the genes themselves.
The US Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has voted unanimously in support of the use of Signifor (pasireotide) for the treatment of patients with Cushing's disease who require medical therapeutic intervention.
Democrats are finding points they agree on in a tenuous accord for the message they want to relay to constituents during the August recess: The health insurance industry is the bad guy, The Washington Post reports.
In breakthrough colon cancer research, scientists at Christiana Care Health System's Center for Translational Cancer Research of the Helen F. Graham Cancer Center & Research Institute have discovered that over-expression of HOXA4 and HOXA9 genes in colon cancer stem cells promotes cell replication and contributes to the overpopulation of stem cells that drives colon cancer development.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher Cutright, OD 792 Silver Bluff Rd, Aiken, SC 29803 Ph: (803) 642-9902 | Dr Christopher Cutright, OD 792 Silver Bluff Rd, Aiken, SC 29803 Ph: (803) 642-9902 |
News Archive
Dispelling the belief that the only way to treat such conditions is by fixing or replacing damaged genes, they instead focused on the field of epigenetics—the study of changes in gene silencing that occur without changes in the genes themselves.
The US Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has voted unanimously in support of the use of Signifor (pasireotide) for the treatment of patients with Cushing's disease who require medical therapeutic intervention.
Democrats are finding points they agree on in a tenuous accord for the message they want to relay to constituents during the August recess: The health insurance industry is the bad guy, The Washington Post reports.
In breakthrough colon cancer research, scientists at Christiana Care Health System's Center for Translational Cancer Research of the Helen F. Graham Cancer Center & Research Institute have discovered that over-expression of HOXA4 and HOXA9 genes in colon cancer stem cells promotes cell replication and contributes to the overpopulation of stem cells that drives colon cancer development.
› Verified 4 days ago
Dr. Priya Patel, O.D Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3553 Richland Ave W, Suite 136, Aiken, SC 29801 Phone: 803-641-4646 | |
Eye Care One Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3553 Richland Ave W, Suite 136, Aiken, SC 29801 Phone: 803-641-4646 | |
Dr. Michael D. Fulford, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 304 Laurens St Nw, Aiken, SC 29801 Phone: 803-649-9561 Fax: 803-649-2664 | |
Michael D. Fulford, Pa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 304 Laurens St Nw, Aiken, SC 29801 Phone: 803-649-9561 Fax: 803-649-2664 | |
Specs Vision Center Of Aiken, Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 792 Silver Bluff Rd, Aiken, SC 29803 Phone: 803-642-9902 Fax: 803-642-8611 | |
Dr. Cari Lynn Moore, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 3521 Richland Ave, Aiken, SC 29801 Phone: 803-641-4646 Fax: 803-641-4648 | |
Dr. Regina Hamlin, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 110 Pepper Hill Way, Aiken, SC 29801 Phone: 803-642-6060 Fax: 803-642-0754 |